Global High Concentration Respiratory Masks Market - 2021-2028
全世界有 6500 萬名中度或重度慢性阻塞性肺疾病患者，稱為 COPD，專家預測這個數字在未來 50 年將繼續增加。預計呼吸系統疾病發病率的增加將推動市場的增長，從而導致對高濃度呼吸口罩的需求增加。
The global high concentration respiratory masks market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
High concentration respiratory masks are used for the administration of oxygen. These are used for continence and critical care patients to provide high concentration oxygen therapy.
The growing incidence of respiratory diseases is expected to drive the growth of the market.
Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. COPD is a leading cause of death in the United States, affecting 16 million Americans and millions more who don't know they have it. It's characterized by increasing breathlessness, with symptoms developing slowly. Though there's currently no cure for COPD, it's often preventable and treatable. The most common cause is smoking.
Moreover, 65 million people worldwide have moderate or severe COPD, and experts predict that this number will continue to rise worldwide over the next 50 years. Therefore, increasing respiratory diseases leads to an increase in demand for high concentration respiratory masks. Thus, from the above statements, the growing incidence of respiratory diseases is expected to drive the market's growth.
Side Effects of the high concentration of oxygen are expected to hamper the market's growth.
Intake of extremely high concentrations of oxygen can lead to serious risk of complications such as lung damage and can even lead to a complete respiratory failure and decreased long-term performances, which is expected to hinder the growth of the high concentration respiratory masks market over the forecast period. For instance, oxygen toxicity is a concern for underwater divers, those on high concentrations of supplemental oxygen (particularly premature babies), and those undergoing hyperbaric oxygen therapy.
COVID-19 Impact Analysis
COVID-19 pandemic has positively impacted the healthcare industry with increased demand for high concentration respiratory masks, which is likely to drive the market during the forecast period. The pandemic has increased in COVID cases globally. For instance, according to World Health Organization, on Jun 29, 2021, there have been 181,007,816 confirmed cases of COVID-19, including 3,927,222 deaths globally. Medical oxygen is a necessary treatment for severe pneumonia caused by COVID-19. There has been increasing inpatients getting admitted to the Intense Care Unit(ICU); due to falling oxygen levels in patients, there is an increase in the demand for the high concentration of respiratory masks.
Moreover, it has caused a dramatic shortage in the supply of respiratory masks, mainly explained by a surge in demand. Additionally, it would be excessively costly for every country to develop a production capacity that matches crisis demand and encompasses the whole value chain. An alternative, more effective and cost-efficient solution in the long-term may involve combining strategic stocks; upstream agreements with companies for rapid conversion of assembly lines during crises (with possible government incentives and coordination); and supportive international trade measures. Thus, it is expected to propel market growth.
Non-Rebreather segment is expected to hold the largest market share in this market segment
The non-rebreather segment dominated the market for High concentration respiratory masks and accounted for the largest revenue share in 2020. The growth is attributed to increasing chronic compression injuries of nerves, increased cellular therapies, and conduits with various natural materials expected to boost the market in the forecast period. According to the article(Frontiers), on 16 October 2020. Peripheral nerve injury treatment is a relevant problem because of nerve lesion high incidence and unsatisfactory regeneration after severe injuries, thus resulting in reduced patient life quality. Moreover, different strategies have been investigated to repair severe nerve injuries characterized by substance loss and improve the regeneration outcome at both motor and sensory levels.
Additionally, a universal ideal conduit does not exist since conduit properties have to be evaluated case by case; nevertheless, because of their high biocompatibility and biodegradability, natural-based biomaterials have great potential to be used to produce nerve guides. Although they share many characteristics with synthetic biomaterials, natural-based biomaterials should also be preferable because of their extraction sources; indeed, these biomaterials are obtained from different renewable sources or food waste, thus reducing environmental impact and enhancing sustainability comparison to synthetic ones. The most studied natural-based biomaterials used to support nerve regeneration are polysaccharides (hyaluronic acid, alginate, chitin and chitosan), proteins (collagen, gelatin, silk fibroin, fibrin, and keratin) and polyesters derived from natural sources [poly (3-hydroxybutyric acid) and poly (3-hydroxybutyric acid-co-3-hydroxyvaleric acid). Nevertheless, hyaluronic acid, alginate and keratin, discussed in the following paragraphs, do not possess enough mechanical strength to be used alone to produce an NGC but can be used as internal fillers for nerve conduits successful results. Their advantages include improved biocompatibility, decreased toxic effects, and enhanced migration of supporting SCs.
Disposable segment is expected to hold the largest market share in this market segment
The disposable segment dominated the market for high concentration respiratory masks and accounted for the largest revenue share in 2020. The benefits are transparent for allowing the face to be visible for patient assessment by healthcare providers and reducing a sensation of claustrophobia experienced by some patients when wearing an oxygen mask. The vast majority of patients having an operation will at some stage wear an oxygen mask and has fewer risks of infections.
North America region holds the largest market share in the global high concentration respiratory masks market.
North America dominated the high concentration respiratory masks market in 2020. The growth is attributed to the growing adoption of oxygen therapy masks to treat various chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD), which are most commonly seen. For instance, according to the Asthma and Allergy Foundation of America, Asthma causes swelling of the airways. It results in narrowing of the airways that carry air from the nose and mouth to the lungs. Approximately 25 million Americans have asthma. It equals about 1 in 13 Americans, including 8 percent of adults and 7 percent of children.
Moreover, asthma is more common in adult women than adult men, and currently, there are about 5.1 million children under the age of 18 with asthma. In 2019, around 44% of children age 18 and younger who had asthma reported having one or more asthma attacks in the past year, and about 47% of children under the age of 5 with asthma had an episode. Therefore, the increasing prevalence of asthma leads to an increase in the demand for oxygen therapy masks.
The high concentration respiratory masks market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Bound Tree Medical, Teleflex Medical, Vyaire Medical, Medline Industries, Salter Labs, Intersurgical , AHA Hyperbarics, Fairmont Medical and Ventlab . The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the high concentration respiratory masks market globally.
High concentration respiratory masks Market Key Companies to Watch
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Moreover, it is operated in 40 countries and more than 12,000 employees.
Teleflex Incorporated, is into the continuous offering of specialty medical devices for a range of procedures in critical care and surgery For instance, air entrainment masks, high-concentration masks, infant oxygen masks, medium-concentration masks and others.
The global high concentration respiratory masks market report would provide an access to an approx.60 market data table, 56 figures and 200pages.
Global High concentration respiratory masks Market- By Type
Global High concentration respiratory masks Market- By Age group
Global High concentration respiratory masks Market - By Application
Global High concentration respiratory masks Market - By End users
Global High concentration respiratory masks Market - by Region
LIST NOT EXHAUSTIVE